Search results

Jump to navigation Jump to search
  • ...te cancer]]. It is a type of [[PARP inhibitor]], which works by preventing cancer cells from repairing their own DNA, leading to cell death. ...is also used in the treatment of metastatic castration-resistant prostate cancer with a specific genetic mutation.
    2 KB (267 words) - 23:24, 5 February 2024
  • ...varian cancer. It is also being studied in the treatment of other types of cancer.  |Type=Cancer terms
    857 bytes (94 words) - 05:24, 9 January 2023
  • ...rs (metastatic tumors) in one or two other parts of the body. For example, cancer cells can spread from the breast to form a new tumor or two in the brain, o |Type=Cancer terms
    1 KB (182 words) - 00:13, 11 January 2023
  • ...that is involved in DNA repair. By inhibiting PARP, talazoparib can cause cancer cells to die. ...mutated]] (gBRCAm) [[HER2-negative]] locally advanced or metastatic breast cancer. Patients must be selected for therapy based on an FDA-approved companion d
    2 KB (241 words) - 00:02, 7 February 2024
  • * [[Molecular oncology]]: Dive into the molecular basis of cancer, understanding how genetic mutations lead to the disease and the developmen ...]] - Loss of appetite for food, which can be a symptom of diseases such as cancer, AIDS, and some neurological conditions.
    171 KB (26,136 words) - 02:28, 15 February 2024